These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9244846)

  • 1. Inflammation, aspirin, and the risk of cardiovascular disease.
    Murray WM
    N Engl J Med; 1997 Aug; 337(6):422; author reply 423-4. PubMed ID: 9244846
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation, aspirin, and the risk of cardiovascular disease.
    Cahill MR; Perry IJ
    N Engl J Med; 1997 Aug; 337(6):422-3; author reply 423-4. PubMed ID: 9244847
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation, aspirin, and the risk of cardiovascular disease.
    Bruno JJ
    N Engl J Med; 1997 Aug; 337(6):422; author reply 423-4. PubMed ID: 9244845
    [No Abstract]   [Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 5. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and ibuprofen: potential mediators of the cardiovascular risk due to smoking?
    Mainous AG; Pearson WS
    Fam Med; 2003 Feb; 35(2):112-8. PubMed ID: 12607808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease. Does inflammation cut to the heart of the matter?
    Taubes G
    Science; 2002 Apr; 296(5566):242-5. PubMed ID: 11951014
    [No Abstract]   [Full Text] [Related]  

  • 9. [C-reactive protein in cardiovascular diseases].
    Lubas W; Gutkowski K
    Przegl Lek; 2006; 63(7):562-6. PubMed ID: 17203810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, aspirin, and the risk of cardiovascular disease.
    Rus H; Niculescu FI
    N Engl J Med; 1997 Aug; 337(6):423; author reply 423-4. PubMed ID: 9244848
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy and clinical trials.
    Duttaroy AK
    Curr Opin Lipidol; 2006 Aug; 17(4):492-4. PubMed ID: 16832176
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation, the metabolic syndrome and cardiovascular risk.
    Tracy RP
    Int J Clin Pract Suppl; 2003 Mar; (134):10-7. PubMed ID: 12793593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
    Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
    Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
    Lubsen J
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
    [No Abstract]   [Full Text] [Related]  

  • 18. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
    Temizhan A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin, NSAIDs, and cardiovascular risk: is there a link?
    Kapoor JR
    Am J Med; 2008 Nov; 121(11):e9. PubMed ID: 18954833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.